Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NRx Pharmaceuticals Presents Evidence ZYESAMI™ (aviptadil) Helps Prevent "Cytokine Storm" in Patients with COVID-19

prnewswireJuly 20, 2021

Tag: NRx Pharmaceuticals , ZYESAMI™ , COVID-19

PharmaSources Customer Service